The Claim
Omega-3 fatty acid supplementation in patients with colorectal cancer is associated with a reduction in post-operative infectious complications and shorter hospital stays.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Patients with colorectal cancer who take omega-3 fatty acid supplements after surgery experience fewer infections and leave the hospital sooner than those who do not.
See the scientific wording
Omega-3 fatty acid supplementation in patients with colorectal cancer is associated with a reduction in post-operative infectious complications and shorter hospital stays.
Omega-3 fatty acids replace other fats in immune cell membranes, which changes how these cells respond to injury. Instead of producing strong inflammatory signals, they produce signals that calm inflammation and help clean up damaged tissue. This reduces overall body inflammation, which allows the immune system to fight infections more effectively after surgery and helps the body recover faster.
What the research says
1 studyPeople with colorectal cancer who took omega-3 supplements after surgery had fewer infections and left the hospital sooner than those who didn’t, according to this study.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.